In Brief
The origin and development route of tissue resident mast cells is unclear. Here, Li et al. show that most connective tissue mast cells derive from fetal mast cells that arise from late erythro-myeloid progenitors generated in the yolk sac at E8.5.
INTRODUCTION
Mast cells are key effectors of type I allergic responses and also are proposed to participate in a wider variety of physiological and pathological processes including organ development (Lilla and Werb, 2010; Liu et al., 2015) , skin-barrier homeostasis (Kurashima et al., 2014) , wound healing (Douaiher et al., 2014) , heart function (Ngkelo et al., 2016) , and tumor progression (da Silva et al., 2014; Giannou et al., 2015) . However, these functions of mast cells are still under debate, because most in vivo studies are based on Kit mutant mouse models that are deficient beyond the mast cell compartment. So, the exact physiological and pathogenic functions of mast cells need to be further studied.
Mast cells predominantly reside in tissues and are subclassified into two main subsets based on their tissue distribution: connective tissue mast cells (CTMCs) are located around venules and nerve endings in most connective tissues (i.e., skin, tongue, trachea, esophagus, adipose, peritoneal cavity, and pleural cavity) and mucosal mast cells (MMCs) are located inside the epithelia of the gut and respiratory mucosa. Both CTMCs and MMCs are heterogeneous based on the distinct nature of their intracellular secretory granule proteases (i.e., chymases, tryptases, and carboxypeptidase). MMCs are inducible and transient with a lifespan of only 2 weeks, whereas CTMCs are constitutive and long-lasting (Dwyer et al., 2016; Gurish and Austen, 2012) . Both development-associated intrinsic factors and external factors in the tissue microenvironment are thought to corporate to shape the properties of these cell subtypes. Therefore, clarification of the origin and developmental route of mast cells is critical for understanding the heterogeneity of mast cells across tissues and thereby their biological functions.
In 1978, Yukihiko Kitamura et al. showed that mast cells can be reconstituted in mast cell-deficient mice by the adoptive transfer of wild-type (WT) bone marrow cells, indicating that mast cells originate from bone marrow (BM). However, they also observed that the mast cell numbers in the skin, unlike the cell numbers in caecum, did not reach the same amounts as in the congenic control WT strain, even 105 days after transfer (Kitamura et al., 1978) . Thus, BM-derived mast cell progenitors (MCPs) cannot completely reconstitute the mast cell pool in the skin. Similarly, reconstitution assays in adult WT mice illustrate that, unlike MMCs, mast cells in the skin are only partially replaced by donor mast cells. This suggests that their maintenance during adulthood is independent of postnatal hematopoietic stem cells (HSCs) (Kitamura et al., 1977) . Whether this also applies to mast cells in other connective tissues and how the adult CTMC pool is maintained are both unknown.
There are three hematopoietic ''waves'' during mouse embryogenesis. Primitive hematopoiesis appears in the extra-embryonic yolk sac at around embryonic day 7.25 (E7.25) and generates early erythro-myeloid progenitors (early EMPs). Then the second transient definitive wave of fetal hematopoiesis, spanning from E8 to E9.5, sequentially generates multi-lineage c-Myb + EMPs (also late EMPs) at the hemogenic endothelium of the yolk sac followed by c-Kit + lympho-myeloid progenitors (LMPs) at the intraembryonic mesoderm. Finally, the definitive hematopoietic wave generating c-Kit + Sca-1 + HSCs with long-term reconstitution activity emerges from E9.5 to E10.5 within the aorta, gonads, and mesonephros region (AGM). Fate-mapping technologies have allowed investigators to trace the contributions of these three hematopoietic waves to adult hematopoietic cells (Hoeffel and Ginhoux, 2015; Kierdorf et al., 2015; McGrath et al., 2015) . For example, it has been shown recently that most tissue-resident macrophages originate from late EMPs, independently of adult HSCs, and are endowed with long-lasting self-renewing activities after birth (Ginhoux and Guilliams, 2016; Gomez Perdiguero et al., 2015; Mass et al., 2016) . Tissue-resident macrophages and skin mast cells share many homeostatic properties such as radio-resistance and self-renewal. We thus wondered whether they might follow a similar embryonic origin and developmental route.
Using limiting dilution assays in vivo, early studies reveal that embryonic precursors of mast cells appear in the yolk sac as early as E9.5, in the fetal liver at E11, and in the embryonic skin at E15 (Hayashi et al., 1985; Kitamura et al., 1979; Sonoda et al., 1983) . Mature metachromatic mast cells can be found in the eye and skin during embryogenesis (Hayashi et al., 1985; Liu et al., 2015) . However, these studies do not clarify the origin of the fetal mast cells or determine whether they contribute to the adult CTMC pool. Herein, we utilized the inducible runt-related transcription factor1 (Runx1-icre) fate-mapping and colony stimulatory factor 1 receptor (Csf1r-icre) fate-mapping systems to study the ontogeny of mast cells. We have shown that early EMPs, late EMPs and fetal HSCs all contributed to fetal mast cells in succession. From late embryogenesis to adult, early EMP-derived mast cells that first colonize tissues are gradually replaced by late EMP-derived mast cells in most connective tissues except in adipose tissue and pleural cavity, leading to late EMP-derived mast cells being a predominant compartment in adult connective tissues, while fetal HSC-derived mast cells are a leading compartment of mucosal mast cells.
RESULTS

Adult Connective Tissue Mast Cells Originate from
Precursors Seeded in Tissues Before Birth and Are SelfMaintained at Steady State Unlike MMCs, adult CTMCs in the skin are poorly reconstituted by donor BM (Kitamura et al., 1977) , indicating different underlying mechanisms for the replenishment of these two types of mast cells. To ascertain the BM-dependence of CTMC homeostasis in adulthood more comprehensively, we adoptively transferred adult CD45.1 + BM cells into lethally-irradiated CD45.2 + recipient mice and analyzed the mast cell compartment eight months later. We found that CTMCs in the skin, peritoneal cavity, tongue, heart, esophagus, and trachea were poorly repopulated by donor-derived HSCs. In contrast, more than 50% of caecum mast cells representing MMCs were of donor origin at that time ( Figure 1A ). To exclude the possibility that perinatal circulating hematopoietic precursors might contribute to adult CTMC homeostasis, we performed BM reconstitution assays in newborn mice. Similarly, donor BM-derived hematopoietic precursors also could not reconstitute the CTMCs in the above tissues in the sublethally irradiated CD45.2 + newborn mice after 8 months of transplantation, while half of the circulating leukocytes and MMCs were of donor origin at that time ( Figure 1B ). These results indicate that CTMCs originate from fetal mast cells that seed the peripheral tissues before birth and are maintained independently of BM-derived HSCs throughout life. As for cecum mast cells, about half were BM-dependent, likely representing intraepithelial MMCs, while another half that were BM-independent may be CTMC-like mast cells in subepithelial connective tissue strata of intestine.
To test whether these embryonic-derived mast cells in connective tissues might be radio-resistant and thereby impede reconstitution by BM cells from the donor, we performed reconstitution assays using mast-cell-deficient Kit w-sh/w-sh mice. Indeed, the mast cells in the skin and peritoneal cavity of lethally irradiated Kit w-sh/w-sh mice could be partially reconstituted by donor BM-derived mast cells ( Figure 1C ). Moreover, donor BM-derived mast cells could also partially reestablish the peritoneal mast cells in recipient mice after deletion of their peritoneal mast cells by water injection (Guermonprez et al., 2013; Kanakura et al., 1988 ) ( Figure 1D ). Thus, BM-derived HSCs are capable of re-establishing these tissue-resident mast cells but only when they are absent.
Metachromatic Mast Cells Arise in Late Embryogenesis
We next went on to verify the presence of mast cells in peripheral tissues at birth. Because Avidin has been confirmed to specifically bind to intracellular granules in mature mast cells (Tharp et al., 1985) , we analyzed the distribution of mast cells in newborn mice by Avidin staining combined with the expression of the stem cell factor receptor c-Kit (CD117), one marker of mast cells. CD117 + Avidin + cells were found in most tissues of newborn mice (Figure 2A ). To confirm that these cells were undoubted mast cells, we prepared the cells in skin, peritoneal cavity, spleen, and brain for toluidine blue staining and chloroacetate esterase reaction. As expected, mast cells with metachromatic granules were observed in these tissues ( Figure 2B ). In the skin, these Avidin + mast cells mainly localized in the dermal layer, while in the spleen, they localized diffusely ( Figure 2C ). In addition, these Avidin + cells also expressed T1/ST2 (IL33R) (Fig (Hoeffel and Ginhoux, 2015; Hoeffel et al., 2012) . We injected 4'OHT at E7.5, E8.5, and E9.5 to respectively trace the progeny cells from early EMPs (injected at E7.5), late EMPs (at E8.5), and fetal HSCs (at E9.5) by detecting EYFP + cells ( Figure 3A ). As mentioned above, mast cells were identified as CD45 + CD11b -CD117 + T1/ST2 + in newborn mice ( Figure 2D ). In embryos with 4'OHT-exposure at E7.5, EYFP + cells accounted for 15%-20% of mast cells in the pleural cavity, adipose tissue, and skin, less than 10% in the rudiments of tongue, heart, lung, and peritoneal cavity, and were sparse in gut and spleen at E18.5; in embryos with 4'OHT-exposure at E8.5, EYFP + mast cells represented 15%-25% of mast cells at E18.5 in all detected tissues except adipose tissue, where their composition percentage were lower than early EMP-derived mast cells; and in embryos with 4'OHT-exposure at E9.5, EYFP + mast cells had a leading distribution in the gut (up to 30%), but were less than early EMP-derived mast cells in the skin, adipose tissue, and pleural cavity, and less than late EMP-derived mast cells in the pleural cavity, skin, peritoneal cavity, and lung ( Figure 3B ). To validate 4'OHT treatments at the precise embryonic age, EYFP + brain microglia, skin macrophages, and blood neutrophils were simultaneously analyzed in the same mouse. Consistent with previous observations, early EMPs mainly contributed to brain microglia, while late EMPs contributed to Please also see Figure S1 .
more tissue-resident macrophages than fetal HSCs before birth ( Figure 3B and Figure S2 ) (Ginhoux et al., 2010; . To further confirm the contribution of early EMPs to fetal mast cells, the Csf1r-icre fate-mapping system with a Cre reporter controlled by the Csf1r promoter was also exploited to specifically trace Csf1r + EMPs (early EMPs) and their progeny by injection of 4'OHT at E8.5, because early EMPs start to express the Csf1r gene from E8.5 onward (Gomez Perdiguero et al., 2015; Hoeffel and Ginhoux, 2015; Qian et al., 2011) . We found that injection of 4'OHT at E8.5 mainly labeled the mast cells in the skin, pleural cavity, and adipose tissue. Mast cells in the trachea, tongue, and heart were also labeled but to a lesser extent, and the gut, lung, and spleen were only marginally labeled (legend continued on next page) (Figures 3A and 3C) . This result is consistent with our observations in the Runx1 cre/EYFP embryos pulsed with 4'OHT at E7.5.
Similarly, we detected a large number of EYFP + microglia, confirming Csf1r + EMPs cells as the main origin of brain microglia. Altogether, these results suggest that fetal tissue-resident mast cells have three hematopoietic origin, but each has different tissue preferences: early EMP-derived mast cells mainly populate the skin, pleural cavity, and adipose tissue; late EMP-derived mast cells distribute in more tissue types and are the predominant population except in adipose tissue and mucosa; and fetal HSC-derived mast cells are a leading population in the mucosa.
Mast Cell Progenitors Can Be Identified at Day E11
We next investigated the route of mast cell differentiation from early, late EMPs, and HSCs using the Csf1r-icre and Runx1-icre fate-mapping systems. Integrin b7 is one confirmed marker of MCPs in adult mice (Chen et al., 2005 Figure 4D ). At E18.5, adoptively transferred integrin b7 + fetal liver cells exclusively gave rise to mast cells in the skin and peritoneal cavity, whereas those integrin b7 -fetal liver cells displayed granulocyte and monocyte potentials, giving rise mainly to neutrophils, monocytes and macrophages ( Figure 4D ). Next, we compared the in vitro differential potentials of integrin b7 + and integrin b7 -fetal liver cells into mast cells by stem cell factor (SCF) and IL-3 stimulation (Wang et al., 2014) . After 7 days of in vitro culture, colonies were generated from sorted CD45 + CD11b low CD117 + integrin b7 + fetal liver cells, but not from integrin b7 -cells ( Figure S3A ). In addition to the expression of CD117
and T1/ST2, around 12.9% of mast cells in these colonies expressed FcεRI, a marker of mature mast cells, further demonstrating their mast cell identity. In contrast, cells displaying such phenotypes were largely absent in integrin b7 -fetal liverderived cells ( Figure S3B ). Thus, CD45 + CD11b low CD117 + integrin b7 + cells were fetal MCPs. Similarly, MCPs are also derived from late EMPs or HSCs, but the number of early EMP-derived MCPs was the most at E11.5 ( Figure 4E and Figure S3C) , indicating that early EMPs were the earliest origin of MCPs. Altogether, integrin b7 + cells from yolk sac EMPs and fetal HSCs are fetal MCPs that first appear at E11.
Fetal Mast Cell Progenitors Complete Their Maturation in Peripheral Tissues
Consequently we analyzed whether integrin b7 + MCPs emerging at E11 colonized and completed their maturation in peripheral tissues by using the Csf1r-icre fate-mapping system. Wholetranscriptome sequencing of early EMPs and their progeny (MCPs, mast cells, and macrophages) during embryogenesis revealed that fetal MCPs acquired the mast cell-specific gene signature from E11.5 and complete their maturation in peripheral tissues ( Figure 5A ). We found that the mRNAs of mast cell-specific genes, including Mrgprb1, Mcpt4, Ndst2, Zfp9, and Fcer1a, were expressed in EYFP + integrin b7 + MCPs but not in EYFP + integrin b7 -EMPs in the fetal liver (Dwyer et al., 2016; McNeil et al., 2015) . The expression of these genes gradually increased in EYFP + MCPs in the limbs from E11.5 to E14.5 and in the skin from E16.5 to postnatal day 5 (P5) ( Figures 5A and 5B). Similar results were observed in EYFP -cells ( Figure S4A ). Along with the progressive expression of T1/ST2 from E11.5 to E18.5, the expression of integrin b7 on mast cells was downregulated from E16.5 onward ( Figure 5C and Figure S4B ). FcεRI was still undetectable on the cell surface of E16.5 mast cells, although we had detected its a subunit at the mRNA level ( Figure S4C ).
We also evaluated the proliferative activity of fetal MCPs using Ki67 staining, and found that MCPs in the skin at E12.5 expressed Ki67 the highest, which was strongly downregulated after birth. Thus, MCPs in tissues had higher proliferative potential before birth that was reduced after birth ( Figure 5D ).
The production of metachromatic granules in mast cells is considered the only gold standard for the maturation of mast cells. Thus we measured the generation of granules in MCPs during embryogenesis using Avidin staining. Not until E16.5 did MCPs begin to produce granules ( Figure 5E ). To verify that these cells were indeed mature mast cells, we performed classical See also Figure S3 . toluidine blue staining and chloroacetate esterase reaction. Consistent with the Avidin staining, both metachromatic and chloroacetate esterase positive granules were clearly observed in the mast cells of skin and peritoneal cavity at E16.5 but not at E15.5, indicating that E16.5 was the time point when mature mast cells developed in the peripheral tissues. E16.5 skin mast cells had stronger chloroacetate esterase activity when compared with peritoneal mast cells, implying that the heterogeneity across tissues begins as early as this time point ( Figure 5F ). In summary, integrin b7 + MCPs from the fetal liver seed and complete their maturation in the peripheral tissues at late embryogenesis.
Late EMP-Derived Mast Cells Are the Major Contributor to Adult Connective Tissue Mast Cells
We were interested to determine whether the CTMCs from the three hematopoietic waves would differ in their fates after birth until adulthood. Consequently, we traced the EYFP + mast cells from birth to adulthood using both the Runx1-icre fate-mapping and Csf1r-icre fate-mapping models. In the Csf1r-icre fate-mapping model, early EMP-derived mast cells retained consistently high abundance in adipose tissue and the pleural cavity from birth to adulthood. However, their numbers in skin dropped markedly at postnatal 2 weeks and were almost undetectable after 4 weeks ( Figure 6A and Figure S5 ). Late EMP-derived CTMCs maintained their dominance in most connective tissues from birth to adulthood except in adipose tissue and the pleural cavity, while HSC-derived EYFP + CTMCs were still the minor contributor to the CTMC pool. The absolute number of mast cells in the skin decreased from postnatal 1week (data not show), and early EMP-derived mast cells sharply dropped from this time point. As a result, the relative abundance of late EMP and fetal HSC-derived mast cells within the skin mast cell pool increased ( Figures 6B and 6C) . Thus, late EMP-derived mast cells composed the majority of the adult CTMC pool in most connective tissues except adipose tissue and the pleural cavity where early EMP-derived mast cells mainly dominated. Additionally, these embryonic mast cells continued to develop into more mature mast cells after birth, characterized by the increased expression of FcεRI and Sca-1 ( Figure 6D ).
Distinct gene Profiles of Skin Mast Cells with Different Fetal Origin
To explore whether mast cells with different origin have specific characteristics or functions, we performed whole-transcriptome sequencing of sorted skin mast cells with different origin at postnatal 1week using fate-mapping systems. We found that a core mast cell transcriptional program was similarly expressed in all the three wave hematopoiesis-derived mast cells, including canonical mast-cell proteases, heparin-sulfate biosynthesis, and Mrgpr family of G-protein-coupled receptors ( Figure 7A ). Unsupervised clustering analysis highlighted the distinction of fetal HSC-derived mast cells from yolk sac EMP-derived mast cells ( Figure 7B ). Analysis of differentially expressed genes (DEGs) showed that late EMP-derived mast cells and fetal HSC-derived mast cells shared 165 common genes upregulated and 94 common genes downregulated when compared with early EMPderived mast cells ( Figure 7C ). Functional pathway-enrichment analysis showed that mast cells derived from late EMPs and fetal HSCs had increased expression of genes related to cell cycle and DNA replication ( Figure 7D) Figure S6 ). Therefore, HSC-derived mast cells are indicated to be more associated with immune responses and inflammatory injuries than the other two origin-derived mast cells. The abnormal elevation of HSC-derived mast cells may be involved in some inflammatory disorders. Therefore, mast cells with different origins display distinct transcriptional profiling, reflecting the heterogeneity of tissue-resident mast cells.
In summary, our study shows that fetal mast cells are derived from all three waves of embryonic hematopoiesis. They all pass through an intermediate stage of integrin b7 + MCPs that appear at E11 and colonize peripheral tissues, where they complete their final maturation with metachromatic granules production in peripheral tissues. We also reveal that mast cells derived from three different origins have distinct tissue-resident preferences and shape the heterogeneity of tissue-resident mast cells in adult animal. Although early EMP-derived MCPs evolve first and are able to populate most tissues during early embryogenesis, they are subsequently replaced by late EMP-derived mast cells in most connective tissues during late embryogenesis and early adulthood, with exceptions in the pleural cavity and adipose tissue.
The consequence of such dynamics is that late EMP-derived mast cells are a leading group of adult CTMC pool in most connective tissues, and early EMP-derived mast cells are limited to adipose and pleural cavity.
DISCUSSION
Tissue-resident mast cells were believed to be derived from undifferentiated mesenchymal cells for around 100 years following their identification by Paul Ehrlich (Ribatti and Crivellato, 2014) . This dogma has been abandoned upon the (E and F) The production of granules by mast cells in the indicated tissues at E15.5 and E16.5 by Avidin staining (E) and by toluidine blue and NASDCE staining (F). Cell suspensions prepared from peritoneal washout or skin digests were spun onto glass slides and stained with toluidine blue or NASDCE. Scale bar represents 50 mm. Data in (C)-(F) was representative of three independent experiments. See also Table S1 and Figure S4 .
discovery by Yukihiko Kitamura's group that mast cells were of HSC origin in 1977 (Kitamura et al., 1977) . Since then, this concept has been continuously reinforced by identifying MCPs in adult BM (Chen et al., 2005) . MCPs from BM-derived HSCs leave the BM and circulate in the blood and eventually enter peripheral tissues and serosal cavities where they can complete their maturation. However, based on the difference in BM-dependence between MMCs and CTMCs under steady-state conditions, we were inspired to study whether they have different origins. Indeed, our study provides strong evidence that unlike MMCs which originate from fetal HSCs and depend on adult HSCs for their replacement, CTMCs originate from yolk sac-EMPs and are maintained independently of adult HSCs throughout life. The recent study on the ontogeny of mast cells by Dr. Gentek et al. draws similar conclusions: adult CTMCs are of fetal hematopoietic origin and can self-maintain independently from BM under steady-state (Gentek et al., 2018) . A major discrepancy between their and our findings relates to which wave of hematopoiesis finally becomes the leading contributor to adult CTMC pool. Such divergence is due to the different inducible fate-mapping models used. By using Cdh5-icre system, Dr. Gentek et al. have indicated that early EMP-derived mast cells are replaced by fetal HSC-derived mast cells, but their work bypasses the late EMP hematopoiesis which may be achieved via inducible activation at E8.5 (Zovein et al., 2008) . So, Dr. Gentek et al. has not found the late EMP as the major contributor to adult CTMC pool. Because some late EMP-derived cells may still express Cdh5 at midgestation, fetal HSC-derived cells traced via the Cdh5-icre may be a mixture of cells derived from late EMPs and HSCs (Taoudi et al., 2005) . However, by using Runx1-icre system to trace the three waves of hematopoiesis separately, our work confirmed the major contribution of late EMP hematopoiesis to adult CTMC pool. In addition, because of the overlap between late EMP and fetal HSC hemotopoiesis, it actually remains difficult to separate them clearly by the current fatemapping models. Such difficulty also reflects on the debates regarding the ontogeny of adult macrophages (late EMPs versus fetal HSCs) using different fate-mapping systems such as Runx1-icre and Kit-icre systems (Sheng et al., 2015) . So, more specific genetic tracers are expected to definitely trace late EMP and fetal HSC hematopoiesis in the future. Late EMP-derived mast cells are long-lived cells and gradually become the major mast cell type in most adult CTMCs. In contrast, fetal HSC-derived mast cells that prefer to localize in mucosa before birth may be short-lived cells, and as a consequence, are constantly renewed by the BM. In the case of early EMP-derived mast cells, it is still unclear what cause them to disappear from the most connective tissues but retain in adipose tissue and the pleural cavity until adulthood. Early EMP-derived cells are not universally short-lived, because early EMP-derived mast cells and early EMP-derived microglia cells are long-lived in adipose tissue and the pleural cavity, and in the brain, respectively. We speculate that an essential factor might be required for the maintenance of early EMP-derived mast cells from late embryogenesis to neonatal period, which is absent in most connective tissues but present in adipose tissue and the pleural cavity. It is also possible that early EMP-derived mast cells are more susceptible to environmental factors that are not present in adipose tissue or the pleural cavity.
Similar to adult BM-derived MCPs, we found that integrin b7 could also be used to define embryonic MCPs. The earliest appearance of integrin b7 is at E11, a time denoting the bifurcation of mast cell-commitment along with the differentiation from the yolk sac-EMPs or fetal HSCs. Along with the gain of integrin b7, the cells start to lose their potential to become macrophages, monocytes, and neutrophils. Integrin b7 together with integrin a4 or aE is the receptor of mucosal addressin on epithelial cells. They direct lymphocytes homing to the gut and mediate their interactions with epithelial cells. In addition to lymphocytes, a4b7 has been reported to be critical for adult HSC-derived MCPs to home to the intestine (Gurish et al., 2001) . Thus, surface expression of integrin b7 on fetal MCPs is essential for directing them to migrate into the developing organs. The interaction of integrin b7 with its ligands or counter-receptors expressed on other cellular types in peripheral tissues may play roles not only in restraining these MCPs in the tissue but also instructing them to further develop into mature mast cells in the tissue microenvironment. With the increasing expression of T1/ST2 and the generation of granules, the expression of integrin b7 is downregulated in these MCPs after E16.5. IL33-triggered T1/ST2 signaling may be critical for the generation of granules by fetal MCPs because it promotes tryptase expression by synovial mast cells (Kaieda et al., 2010) . However, fully elucidating the roles of integrin b7 and T1/ST2 during fetal mast cell development requires further study.
Macrophages, Langerhans cells (LCs), and mast cells all belong to tissue-resident immune sentinels. They all complete their development before birth and are derived from yolk sacEMPs. Macrophage differentiation is now regarded as an integral part of organogenesis, and macrophages are important for the morphogenesis of many organs beyond its role in immune defense (Gordon and Martinez-Pomares, 2017; Kierdorf et al., 2015; Mass et al., 2016) . This viewpoint also applies to mast cells. Liu et al. have reported that there are two different waves of mast cell migration during corneal development. The first wave of mast cells migrates to the corneal stroma at E12.5 and then disappears at the time of eyelid opening (postnatal day 13). We speculate that the first wave of mast cells may be early EMP-derived due to as the earliest differentiated population and disappearance at postnatal day 13, a time point that is similar to our observation of early EMP-derived mast cells disappearing in the skin two weeks after birth. The second wave maybe involved in the formation of limbal blood vessels and the corneal nerve fiber, which migrates to the corneal limbus after birth . The distinct anatomical distribution of mast cells with different origin raises another very interesting possibility that these mast cells may play distinct roles in shaping the microenvironment of different tissues during organogenesis. To date, the physiological functions of fetal tissue-resident mast cells in organ development during the perinatal period, and whether these non-or hypo-granulated MCPs have independent function(s) during embryonic development, are still unclear.
Our findings delineate the origin and development route of mast cells before birth. They also raise several areas for future investigation: identifying the master transcription factors that direct mast cell differentiation from distinct origin; elucidating the mechanisms underlying their tissue preferences and metachromatic granule generation after they reside in tissues; discovering why and how late EMP-derived mast cells deprive primitive mast cells in most connective tissues. A comprehensive understanding of mast cell ontogeny will open the door not only to understand their heterogeneity and mast-cell-associated immunity, physiology and pathophysiology, but also to design mast cell-targeted therapeutic interventions for allergic and autoimmune diseases.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: as previously (Gomez Perdiguero et al., 2015; Samokhvalov et al., 2007) . Embryonic development was estimated as 0.5 days post-conception on the time of vaginal plug observation. Recombination was induced by intraperitoneal injection with 4-' OHT (2.5mg/mouse) (Sigma) and progesterone (1.5mg/mouse) (Sigma) that were dissolved in sunflower oil (Sigma) into pregnant mice respectively at E7.5, E8.5 or E9.5. Cesarean sections were operated at E18.5 due to 4'OHT treatment interfering with normal delivery, and neonates were nursed by lactating mice (Hoeffel et al., 2012) .
Reconstitution assays CD45.2 + C57BL/6 or Kit w-sh/w-sh (8 weeks) were lethally irradiated using a cobalt 60 source for 2 3 600 rad (4h apart), and then reconstituted with 2 3 10 6 bone marrow cells from CD45.1 + C57BL/6 (2 weeks). For reconstitution assay in newborn mice, CD45.2 + C57BL/6 pubs were irradiated using a cobalt 60 source (2 3 300 rad, 4h apart) and reconstituted with 1 3 10 6 bone marrow cells from CD45.1 + C57BL/6 by injection into the liver using a 33-gauge needle (Hamilton) (Hoeffel et al., 2012 cells per embryo) as previously described (Hoeffel et al., 2012) . Pregnant mice were anaesthetized using anesthesia breathing systems.
PCR genotyping DNA was amplified with the primers of oIMR4982, oIMR8545 and oIMR8546 to identify Rosa26 locus genotyping and with the primers of oIMR9266 and oIMR9267 to Csf1r-Mer-cre-Mer genotyping, as recommended by the Jackson Lab. For genotyping of Runx1-Mercre-Mer, DNA was amplified with the primers tbd2, exo31 and exo32 (Samokhvalov et al., 2007) .
Cell suspension preparations
Embryos ranging from E9.5 to E18.5 were removed from the uterus and washed in cold saline. Embryos were decapitated and blood cells were collected in heparinized saline. Yolk sacs were harvested from E9.5 to E11. Organs except brain, spleen and fetal liver were cut into small pieces and incubated in RPMI 1640 medium (GIBCO) containing 1 mg/ml collagenase IV (Invitrogen), 50ug/ml DNase I (Sigma) and 10% fetal calf serum (FCS, Invitrogen) at 37 C (15 min for embryos between E9.5 and E16.5 and 30 min for embryos of E18.5). Brain, spleen and fetal liver were removed and forced through 70 mm sieves without collagenase digestion. Postnatal tissues including tongue, trachea, esophagus, heart, lung and adipose tissue (1week to 10 months) were cut into small pieces, incubated in RPMI 1640 medium containing collagenase IV (1 mg/ml for mice of 1 to 4weeks and 1.5mg/ml for mice of 8 to 10 months), 50ug/ml DNase I, 50ug/ml dispase(GIBCO) and 10% FBS at 37 C for 30min. Blood cells, cells from peritoneal cavity and pleural cavity were collected before preparation of tissue cells above. Ears or skins of mice from 2 weeks to 16 weeks were incubated with 2 mg/ml dispase at 37 C for 45min to separate dermal sheet from epidermal sheet before collagenase incubation as previously described (Hoeffel et al., 2012) . Caecum from adult mice was cut into pieces and subjected to repeated 30 min incubations in HBSS containing HEPES (15mM) and EDTA (5mM) at 37 C. The remaining tissue was washed with RPMI 1640 medium containing 10% FBS and digested with 1 mg/ml collagenase IV, 50ug/ml DNase I, 50ug/ml dispase and 10% FBS in 1640 RPMI for two 15min cycles at 37 C to release lamina propria cells (Burton et al., 2013) . After digestion, samples were passed through 70 mm sieves to obtain single-cell suspensions. For brain suspensions, brain was isolated and forced through 70 mm sieves without collagenase treatment. Cell suspensions from tongue, caecum, brain, heart and lung were centrifuged on percoll-density (GE Healthcare) to enrich for the leukocyte populations.
Cell Culture Sorted integrin b7
+ cells or integrin b7 -cells from E11.5-12.5 DsRed +/À fetal liver were cultured with SCF (10 ng/ml) and IL-3 (10ng/ml) (Peprotech EC Ltd) in vitro (Wang et al., 2014) . After 7 days, colonies in the culture were observed under fluorescence microscope and analyzed by flow cytometry.
Avidin labeling of tissues from newborn mice Skin and spleen dissected from newborn mice were embedded in O.C.T. Compound and frozen, and 10 mm sections were made using a crytostat (Microm HM 525) and then fixed onto slides. Slides were fixed for 5min at 21-23 C with 2% paraformaldehyde and incubated with 1/500 Avidin-FITC in BD Perm/Wash buffer for 40 min at 21-23 C, and washed with PBS before immediate imaging.
Immunohistochemistry analysis
Cell suspensions prepared from peritoneal washout or tissue digests were spun onto glass slides using a cytocentrifuge7620 (WESCOR) by centrifuging at 1000 rpm for 5 min. Cytospins were stained with toluidine blue(Sigma) or Naphthol AS-D Chloroacetate (Sigma) for the identification of mast cells.
Flow cytometric analysis
Flow cytometric studies were performed using cytometry (Becton Dickinson LSRII and Fortessa) and analyzed using FACSDiva software (Becton Dickinson) or FlowJo software (Tree Star). MoFlo TM XDP (Beckman Coulter) and SH800 (Sony) were used for cell sorting. Cell suspensions were stained with the fluorescence-conjugated primary antibodies or corresponding isotype Ig with or without fixing/permeating treatments as previously described (Ding et al., 2016 Table S1 . pulsed with 4'OHT at E8.5 and from Runx1 cre/EYFP mice pulsed with 4'OHT at E8.5 and E9.5 respectively. The purity of sorted cells was 100% after two rounds of sorting. 6000 sorted cells corresponded to five to six mice from at least two independent experiments were used for RNA extraction. To validate data from the above treatments at the precise embryonic age, EYFP + brain microglia, lung macrophages and blood neutrophils were simultaneously analyzed in the same mice. Only the cells sorted from precise treatments were used for RNA-seq. Total RNA was extracted with Trizol according to the consortium's standard protocols as mentioned above. cDNA was generated with the SMART-Seq v4 Ultra Low Input RNA kit (Clontech). Sequencing was performed on the Illumina HiSeq2500 platform by Beijing Genomics Institute. Further analysis of the result was performed as previously described (Zhang et al., 2015) .
RNA-seq analysis
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical significance of comparisons between two groups was analyzed with Student's t test. Differences were considered to be statistically significant when P values were less than 0.05.
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